Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2
infection, with the majority having minimal to mild symptoms. Additionally, some succumb to …

Objectives We aimed to prospectively describe the incidence and clinical spectrum of SARS-
CoV-2 infection in immunocompromised paediatric patients in the UK. Methods From March …

Further information continued to arrive from all over the world. Media reported on twelve
critically or mortally ill children before April 6, 2020 [13]. There was concern in early Chinese …

Background The uncertainties surrounding the COVID-19 pandemic have been associated
with increased parental concern. The aim of this study is to explore if this increased level of …

The COVID-19 pandemic has proved unique in both its unpredictability and the extent to
which it has continued to impact on daily life since March 2020. Among the …

Objectives Immunosuppressed paediatric patients with rheumatic disease (RD) may be at
risk for severe or critical disease related to severe acute respiratory syndrome coronavirus 2 …

Methods A questionnaire was distributed to members of national and international paediatric
nephrology societies (European Society of Pediatric Nephrology, Asian Society of Pediatric …

Pulmonary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
children is generally described as mild, and SARS-CoV-2 infection in immunocompromised …

The site of “one of the world's strictest and longest running stay-at-home mandates,”
lockdowns in Ontario have become a source of contention within provincial public discourse …

Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new
class of antiviral agents approved as a type of passive immunotherapy. They should be …